Top Markets
Coin of the day
Moleculin Biotech, Inc. Moleculin Biotech, Inc.

Moleculin Biotech, Inc.

MBRX
Rangering i aksjer #35911
Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to... Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
Aksjekurs
$0.6155
Sist synkronisert: 2026-08-14
Markedsverdi
$3.28M
Endring (1 dag)
7.74%
Endring (1 år)
-96.39%
Land
US
Handel Moleculin Biotech, Inc. (MBRX)

Kategori

Aksjeprishistorikk for Moleculin Biotech, Inc. (MBRX)
Høyeste sluttskurs: $0.48 den 2026-08-01

Laveste sluttskurs: $16.17K den 2016-06-01
Aksjeprishistorikk for Moleculin Biotech, Inc. fra 2016 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 8.33%
2025 -90.56%
2024 -77.07%
2023 -51.53%
2022 -36.45%
2021 -59.01%
2020 -17.81%
2019 -15.25%
2018 -35.47%
2017 -12.10%
2016 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE